Topical 2% Povidone-Iodine Gel in Verruca Vulgaris

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Warts

In brief

This is a multi-center, randomized, double-blind, placebo-controlled phase 2 study in subjects 8 years of age and older who present with verruca vulgaris (common warts) and desire treatment. Subjects may have up to a total of 6 common warts located on their trunk or extremities that will be treated with study medication and followed throughout the study protocol therapy. All warts will be treated two times per day (BID) for12 weeks. Approximately 90 subjects will be enrolled in this study.

Key facts

Study ID
NCT04253912
Run by
Veloce BioPharma LLC
People needed
90
Starts
2020-02-12
Expected to finish
2021-04-01
Last updated by the study team
2021-04-01

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.